Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is one of the Best Stocks to Buy for the Next 3 Months According to Hedge Funds. On September 2, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) with a price target of $80. The analyst noted the company’s recent deal with Novartis as a strong vote of confidence. The deal brings$200 million upfront, which has the potential to lead to a $2 billion milestone. Trucchio highlighted that this deal valid ...